Description

Befiradol is a high-purity pharmaceutical intermediate and research chemical with significant potential in modern drug discovery and development. This compound is valued for its role as a key building block in synthesizing novel therapeutic agents, particularly within the central nervous system (CNS) and neuropharmacology research sectors. It is essential for pharmaceutical manufacturers, advanced research institutions, and fine chemical suppliers targeting the development of next-generation medications.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel active pharmaceutical ingredients (APIs).
• Neuropharmacology Research: Used as a reference standard and building block in the development of compounds targeting serotonin and other neurotransmitter systems.
• Medicinal Chemistry: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Preclinical Development: Employed in the formulation of candidate drugs for pharmacokinetic, pharmacodynamic, and toxicology studies.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for biochemical and pharmacological investigations.

Basic Information

Product Name	Befiradol
CAS No.	208110-64-9
Molecular Formula	C17H24N2O2
Molecular Weight	288.39 g/mol
Synonyms	F 13640; Befiradol hydrochloride; 1-[2-(4-Fluorobenzoylamino)ethyl]-4-(7-methoxy-1-naphthyl)piperazine; 4-(7-Methoxy-1-naphthyl)-1-[2-[(4-fluorobenzoyl)amino]ethyl]piperazine; F13640; 1-[2-[(4-Fluorobenzoyl)amino]ethyl]-4-(7-methoxy-1-naphthyl)piperazine
EINECS	Contact for details

Quality Control

Our Befiradol is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including HPLC for assay and impurity profiling, to meet the stringent requirements of pharmaceutical R&D and production. A Certificate of Analysis (COA) detailing identity, purity, and related substances is provided with every shipment to support your quality assurance and regulatory documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.